glp-1 and levothyroxine 10 Surprising Facts About GLP-1/GIP Medications in Hypothyroid Patients GLP-1 Receptor Agonists and Thyroid

A prescription or Letter of Medical Necessity may be required

The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)

Current challenges in diabetes and obesity management Obesity and diabetes are becoming increasingly common worldwide, presenting serious challenges for public health that cannot be ignored

Patients who stay consistent with follow-ups and track their progress often see better long-term outcomes compared to those who rely on medication alone

European Journal of Clinical Nutrition

Some act primarily through GLP-1 pathways, while others affect more than one incretin hormone pathway